Neurocrine Bioscience buy Morgan Stanley
Start price
12.06.24
/
50%
€124.65
Target price
12.06.25
€147.54
Performance (%)
7.78%
Price
22:26
€134.35
Summary
This prediction is currently active. With a performance of 7.78%, the BUY prediction by Morgan_Stanley for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 12.06.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 0.918% | 0.918% |
iShares Core DAX® | -5.630% | -5.765% |
iShares Nasdaq 100 | -8.559% | -13.005% |
iShares Nikkei 225® | -9.576% | -9.058% |
iShares S&P 500 | -6.631% | -7.103% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $160.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-1.61%
22:26
22:26